← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
175 ta ish
Ish: CAR-T cell combination therapy: the next revolution in cancer treatment
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp, Kathrin Schumann, Kole T. Roybal +4
MaqolaOchiq kirish20174 iqtibosABINKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma
Tobias Weiß, Michael Weller, Matthias Gückenberger +2
MaqolaOchiq kirish20174 iqtibosABIOncolytic virotherapy
Stephen J. Russell, Kah-Whye Peng, John C. Bell
Sharh maqolaOchiq kirish20124 iqtibosABICRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
Wanghong Hu, Zhenguo Zi, Yanling Jin +5
MaqolaOchiq kirish20183 iqtibosABIγ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma
Margot J. Pont, Tyler Hill, Gabriel O. Cole +14
MaqolaOchiq kirish20193 iqtibosABIOncolytic viruses: challenges and considerations in an evolving clinical landscape
Sharh maqolaOchiq kirish20223 iqtibosABITargeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang, Ji Nie, Xuelei Ma +3
Sharh maqolaOchiq kirish20192 iqtibosABIHuman CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
Leonid Cherkassky, Aurore Morello, Jonathan Villena‐Vargas +5
MaqolaOchiq kirish20162 iqtibosABITethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
Lenka V. Hurton, Harjeet Singh, Amer Najjar +12
MaqolaOchiq kirish20162 iqtibosABI